<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mississippi Business Journal &#187; Doris Taylor</title>
	<atom:link href="http://msbusiness.com/blog/tag/doris-taylor/feed/" rel="self" type="application/rss+xml" />
	<link>http://msbusiness.com</link>
	<description>Mississippi Business Journal</description>
	<lastBuildDate>Fri, 24 May 2013 20:36:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Taylor joins THI</title>
		<link>http://msbusiness.com/blog/2012/02/12/taylor-joins-thi/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=taylor-joins-thi</link>
		<comments>http://msbusiness.com/blog/2012/02/12/taylor-joins-thi/#comments</comments>
		<pubDate>Sun, 12 Feb 2012 06:01:44 +0000</pubDate>
		<dc:creator>MBJ Staff</dc:creator>
				<category><![CDATA[Newsmakers]]></category>
		<category><![CDATA[Doris Taylor]]></category>
		<category><![CDATA[Duke University Medical Center]]></category>
		<category><![CDATA[Mississippi University for Women]]></category>
		<category><![CDATA[St. Luke's Episcopal Hospital]]></category>
		<category><![CDATA[Texas Heart Institute]]></category>
		<category><![CDATA[University of Minnesota]]></category>
		<category><![CDATA[University of Texas Southwestern Medical School]]></category>

		<guid isPermaLink="false">http://msbusiness.com/?p=52190</guid>
		<description><![CDATA[<p>Doris Taylor, PhD, FAHA, FACC, a leading cell therapy and cardiac regeneration scientist, has joined the Texas Heart Institute (THI) at St. Luke&#8217;s Episcopal Hospital in Houston. Taylor&#8217;s research includes cell and gene therapy for treatment of cardiovascular disease; tissue engineering of bioartificial organs and vasculature, cell-based prevention of disease; stem cells and cancer and [...]</p><p>The post <a href="http://msbusiness.com/blog/2012/02/12/taylor-joins-thi/">Taylor joins THI</a> appeared first on <a href="http://msbusiness.com">Mississippi Business Journal</a>.</p>]]></description>
		<wfw:commentRss>http://msbusiness.com/blog/2012/02/12/taylor-joins-thi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
